Alkermes VIVITROL medicine for treatment of opioid dependence Alkermes.

today announced that the U.S. VIVITROL is now the first and only non-narcotic, nonaddictive, once-monthly medication approved for the treating opioid dependence. VIVITROL was authorized by the FDA in 2006 for the treating alcohol dependence and really should be used as part of a thorough management program which includes psychosocial support. Marc Fishman, Assistant Professor of Psychiatry, Department of Behavioral and Psychiatry Sciences, Johns Hopkins University College of Medicine. 'VIVITROL is an opioid-blocking medication that provides physicians and sufferers a once-monthly medication to prevent relapse to opioid addiction.' 'As a business that helps families find treatment and offers support for loved ones with addiction, we discover firsthand that opioid dependence is one of the most significant health issues facing our nation.Other activities planned this complete year include networking events in various cities around the country, giving young surgeons exclusive opportunities to engage with their peers and additional more senior leaders in the field and from the organization. The success of the activities will rely seriously on current member involvement and willingness to connect the value of ACS membership to colleagues and peers in a way that resonates more with younger generation - smaller sized, shareable bites of information and peer-to-peer influence. Just as the ACS Inspiring Quality initiative became a cornerstone of our organization to advance medical quality around the country, we can build on those attempts by helping young surgeons realize the potential of their job through ACS, stated David B.